Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is currently no recognized, functionally described molecule known as "GAS5 antisense RNA 1" or "GAS5-AS1" in authoritative scientific literature or gene databases. The canonical and biologically important entity is "Growth arrest-specific 5" (GAS5), a long non-coding RNA (lncRNA) implicated in tumor suppression, regulation of apoptosis and cell proliferation, and the modulation of signaling pathways, especially those involving the glucocorticoid receptor[2][3][4][5]. The existence and molecular or therapeutic relevance of a specific antisense transcript called GAS5-AS1 is unsupported by leading evidence or accepted classification.
None known for GAS5-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest-specific 5 antisense RNA 1 (GAS5-AS1).